קם-רהו די I.M

Država: Izrael

Jezik: hebrejščina

Source: Ministry of Health

Aktivna sestavina:

ANTI-D IMMUNOGLOBULINS

Dostopno od:

KAMADA LTD, ISRAEL

Koda artikla:

J06BB01

Farmacevtska oblika:

תמיסה להזרקה

Sestava:

ANTI-D IMMUNOGLOBULINS 150 MCG/ML

Pot uporabe:

תוך-שרירי

Tip zastaranja:

מרשם נדרש

Izdeluje:

KAMADA LTD, ISRAEL

Terapevtska skupina:

ANTI-D (RH) IMMUNOGLOBULIN

Terapevtsko območje:

ANTI-D (RH) IMMUNOGLOBULIN

Terapevtske indikacije:

Pregnancy/other obstetric conditions, Suppression of Rh immunization in non-sensitized Rh0 (D) negative women delivering an Rh0 positive baby or when the baby's Rh type is unknown. Suppression of Rh immunization after spontaneous or induced abortions threatened abortion associated with maternal bleeding amniocentesis chorionic villus sampling ruptured tubal pregnancy and significant abdominal trauma. Kam Rh0 -D IM should be given within 72 hours of the event. It may be given even after up to one month although efficacy may be somewhat reduced.Transfusion: Suppression of Rh isoimmunization in Rh0 (D) antigen-negative patients transfused with Rh0 (D) antigen-positive RBCs of blood components containing Rh0 (D) antigen-positive RBCs . Initate treatment within 72 hours of exposure.

Datum dovoljenje:

2022-01-31